Search - tctmd.com

Displaying 721 - 740 of 1248

Sort: Relevancy | Date

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Daily News

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Yael L. Maxwell

August 29, 2019

News Daily News

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

Caitlin E. Cox

August 23, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: The Push for High-Sensitivity Troponin

August 02, 2019

News Daily News

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Marcus A. Banks

July 24, 2019

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Todd Neale

July 24, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Todd Neale

July 16, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Industry News

Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories

June 07, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News SCAI 2019

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Yael L. Maxwell

June 03, 2019

News Conference News ESC Heart Failure 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Shelley Wood

May 28, 2019

Advertisement

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Radial PCI Up, but Vascular Complication Rates Haven’t Budged

Protracted Opioid Use Not Uncommon After Cardiothoracic Surgery

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Conversations in Cardiology: The Push for High-Sensitivity Troponin

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Jubilant DraxImage Inc. Receives CE Mark Certificate for Its Medical Device RUBY Rubidium Elution System™ (RbES) and Proprietary RUBY™ Consumable Accessories

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content